Ocular Toxicology

Charles River performs safety and efficacy assessments for all ocular indications. Ocular effects of compounds administered by other routes, such as oral, can also be characterized. These studies can be conducted under GLP or non-GLP conditions, either as stand-alone studies or as part of general and specialty toxicology programs. Non-GLP pilot or proof-of-concept studies, as well as in vitro ocular irritancy evaluations are also available for your early research.

Visit the Source℠ for additional information on our ocular research capabilities.

  • Species
    • Rodent
    • Nonrodent
  • Compound Classes
    • Small molecule
    • Biologics
    • Cell therapy
    • Gene therapy
    • Implants/transplants
  • Specular microscopy for noninvasive, in vivo evaluation of the corneal endothelium
  • Electroretinography
  • Spectral domain optical coherence tomography (SD-OCT, anterior and posterior)
  • Tonometry (IOP) evaluations
  • Pachymetry (corneal thickness)
  • Digital fundus photography/video
  • Confocal scanning laser ophthalmoscope (multiple image modes - infrared and tomography for 3D images)
  • Fundus autofluorescence
  • Fluorescein angiography (FA) and Indocyanine green angiography (ICG)
  • Vitrectomy
  • Quantitative autoradiography
  • Ocular and systemic tissue distribution
  • Enhanced microscopic evaluation
  • Ocular surgery/implant

You may also be interested in...

Optimizing Toxicology Study Designs

Using microsampling in toxicology studies achieves two of the 3R objectives – refinement and reduction – while allowing for more parameters to be analyzed and evaluated.

Together We See a Cure

Watch a video highlighting our integrated approach to ophthalmology research, every step of the way.

Miss Us at SOT 2017?

Access the recordings of our four exhibitor sessions and downloadable versions of our poster presentations.